Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Novare Surgical

Request full access

Novare Surgical Systems develops motion hand-held laparoscopic instruments to conduct minimally invasive surgeries

Cupertino, United StatesFounded 1999Biotechnology

About Novare Surgical

Novare Surgical Systems, Inc. was a medical device company focused on the development and manufacturing of instruments for minimally invasive surgery (MIS). Founded in 1999 by Thomas J. Fogarty and Kerry Pope, the company was headquartered in Cupertino, California. Pope, who served as President and CEO until 2009, brought experience from roles at Baxter International and Computer Motion, Inc., a developer of robotic surgical systems. Fogarty was a notable figure in the medical field, known for inventing the Fogarty clamp.

The company's core business was manufacturing and supplying surgical equipment, including laparoscopic instruments, electrosurgical instruments, and surgical clamps. Initially, Novare Surgical focused on developing devices for cardiac surgery, building upon Fogarty's work on atraumatic occlusive clamps. A significant shift in focus occurred with the internal development of the RealHand technology platform, redirecting the company towards the broader minimally invasive surgery market. The business model centered on selling these specialized surgical instruments to healthcare facilities for use by surgeons in various procedures.

Novare Surgical's flagship product line was the RealHand High Dexterity (HD) instruments. These were among the first full-range-of-motion, hand-held laparoscopic instruments, designed to address the ergonomic and clinical challenges of MIS. The instruments utilized a proprietary EndoLink mechanism, which allowed the instrument's tip to mirror the surgeon's hand movements, providing tactile feedback and seven degrees of freedom without requiring additional hardware. This design enabled surgeons to perform complex maneuvers with greater control and dexterity, particularly in single-port laparoscopic surgeries where all instruments are inserted through a single incision, often in the patient's navel. The product range included graspers, dissectors, cautery tools, and needle holders, used in a wide array of procedures such as hysterectomies, gastric bypasses, and colectomies. The RealHand instruments received FDA 510(k) clearance and the CE mark, and were recognized with a 2008 Medical Design Excellence Award.

Throughout its operation, Novare Surgical raised a total of $32.3 million in funding over several rounds, including a $16 million Series D round in 2006 to commercialize the RealHand instruments. Key investors included Point Judith Capital, Tudor Investment Corp., Canaan Partners, and Deerfield Partners. Despite its product advancements and successful clinical applications, including enabling numerous 'first-ever' single-port procedures, the company eventually faced financial difficulties. In February 2011, Novare Surgical underwent liquidation. Following this, in February 2011, Vitalitec International, Inc. acquired the ENCLOSE II Anastomosis Assist Device from Novare.

Source: Dealroom company data

At a glance

Status
Closed
Employees
6
Open positions
None listed

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES D✓Equity / VC Oct 2006 $16M $64M PJC · Tudor Investments —
SERIES C✓Equity / VC Jun 2002 $9.8M $39M Canaan · Channel Medical Partners · Atherton Venture Partners · Three Arch Partners —
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Novare Surgical website traffic

Latest recorded traffic for Novare Surgical is 0 monthly website visits. Novare Surgical's team grew 0% over the past year.

Latest monthly visits0 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Novare Surgical in the Cupertino ecosystem

Live from Dealroom

The Novare Surgical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

6 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later6 investors entered at this stage

  • Channel Medical Partners
  • Canaan
  • Atherton Venture Partners
  • Three Arch Partners
  • PJC
  • Tudor Investments
Team profiled 7 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · Cupertino HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Novare Surgical on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Novare Surgical’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.